October 2022 – Page 3 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2022-10-10

Colonoscopy unfortunately is not a miracle cure for colorectal cancer. According to study published inNEJM is not better than the fecal samples

On October 10 the world’s first randomized study on using colonoscopy-screening to prevent colorectal cancer was presented during the 2022 United European Gastroenterology Week in Vienna. The full study was also published in New England Journal of Medicine. “Colonoscopy unfortunately is not a miracle cure for colorectal cancer. According to our study, it probably is not better

No Comments InRESEARCH

PIER MARIA FORNASARI
2022-10-10

A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets: a Cleveland Clinic study finds.

A Cleveland Clinic-led research team used artificial intelligence to map out hundreds of ways that the virus that causes COVID-19 interacts with infected cells. Through this analysis, they identified potential COVID-19 medicines within thousands of drugs already approved by the FDA for other treatments. The research focused on host-targeting therapies, which operate differently from other

No Comments InCovid-19

PIER MARIA FORNASARI
2022-10-10

Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness, Penn Study Finds

Patients’ low-light sensitivity improved by factors of thousands in a clinical trial Adults with a genetic form of childhood-onset blindness experienced striking recoveries of night vision within days of receiving an experimental gene therapy, according to researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania. The patients

No Comments InGENE THERAPY RARE DISEASES

PIER MARIA FORNASARI
2022-10-10

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

Women and people who needed to be hospitalized with Covid are much more likely to develop long Covid, according to a new peer reviewed study published in JAMA on Monday, offering new insight into the persistent and sometimes disabling condition as researchers push to develop new treatments and cures. KEY FACTS An estimated 6% of people with symptomatic Covid infections develop

No Comments InCovid-19

PIER MARIA FORNASARI
2022-10-10

Avoiding Hip Replacement: How Stem Cells Can Treat Avascular Necrosis

A Yale Medicine orthopaedic surgeon has developed an innovative procedure that uses a patient’s own stem cells to treat a condition that can cause painful hip fractures. The condition, called avascular necrosis, is when the flow of blood to the bones is cut off or reduced. It can be caused by a trauma, such as a

No Comments InREGENERATIVE MEDICINE

PIER MARIA FORNASARI
2022-10-09

The SARS-CoV-2 XBB wave starts in Singapore

The world’s first wave of the recombinant SARS-CoV-2 variant XBB has apparently begun in Singapore. Twitter is alight with posts claiming that the recombinant SARS-CoV-2 variant XBB is creating a new wave of infections in Singapore, so we’ve taken a look at the latest information from the Singapore Ministry of Health and other reliable sources

No Comments InCovid-19

PIER MARIA FORNASARI
2022-10-05

New study reveals possible brain mechanisms behind COVID-19 delirium

Researchers from King’s College London have shown that when brain cells are directly exposed to blood taken from COVID-19 patients with delirium, there is an increase in cell death and a decrease in the generation of new brain cells. Delirium represents a state of confusion indicating that, in these patients, the COVID-19 infection had impacted

No Comments InCovid-19

PIER MARIA FORNASARI
2022-10-05

Study Provides Further Evidence That Immune Cell Dysregulation is a Driver of COVID-19 Severity

Maintenance of reparative lung macrophages may be a viable therapeutic strategy for the treatment of SARS-CoV-2 and other inflammatory lung diseases In one of the largest single-center COVID-19 cohort studies to date, researchers at the Icahn School of Medicine at Mount Sinai, using samples collected during the peak of the pandemic in New York City,

No Comments InCovid-19

PIER MARIA FORNASARI
2022-10-05

Coronavirus formation is successfully modeled

A physicist at the University of California, Riverside, and her former graduate student have successfully modeled the formation of SARS-CoV-2, the virus that spreads COVID-19, for the first time. In a paper published in Viruses, a journal, Roya Zandi, a professor of physics and astronomy at UCR, and Siyu Li, a postdoctoral researcher at Songshan Lake Materials Laboratory in

No Comments InCovid-19

PIER MARIA FORNASARI
2022-10-04

NIH RECOVER initiative to understand Long-Term COVID-19 Symptoms and Enhance Recovery

We are in the third year of the COVID-19 pandemic, and across the world, most restrictions have lifted, and society is trying to get back to “normal.” But for many people—potentially millions globally—there is no getting back to normal just yet. They are still living with the long-term effects of a COVID-19 infection, known as

No Comments InCovid-19

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Archives: 2022-10-10

Colonoscopy unfortunately is not a miracle cure for colorectal cancer. According to study published inNEJM is not better than the fecal samples

A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets: a Cleveland Clinic study finds.

Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness, Penn Study Finds

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

Avoiding Hip Replacement: How Stem Cells Can Treat Avascular Necrosis

The SARS-CoV-2 XBB wave starts in Singapore

New study reveals possible brain mechanisms behind COVID-19 delirium

Study Provides Further Evidence That Immune Cell Dysregulation is a Driver of COVID-19 Severity

Coronavirus formation is successfully modeled

NIH RECOVER initiative to understand Long-Term COVID-19 Symptoms and Enhance Recovery